“HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome”, UTJsci, vol. 5, no. 3, pp. 48–56, Dec. 2015, doi: 10.32792/utq/utjsci/v5i3.138.